Evoke Pharma (EVOK) announced the appointment of Greg Pyszczymuka to its Board of Directors, effective February 20, 2025. This marks the second board member appointment by Nantahala Capital Management, reinforcing its continued confidence in Evoke’s commercial strategy and growth potential. He currently serves as Chief Commercial Officer at Aytu BioPharma (AYTU).
Education
About Us
Working with TipRanks
Follow Us
1